Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionIntegrated Wealth Concepts LLC
Latest Disclosed Ownership22,643 shares
Latest Disclosed Value $ 3,458,688
Integrated Wealth Concepts LLC reports 121.86% increase in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Integrated Wealth Concepts LLC filed a 13F-HR form disclosing ownership of 22,643 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $3,458,718 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,206 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 121.86% during the quarter. The current value of the position is $3,252,893 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS Common Stock 66987V109 22,643 12,437 121.86 3,459 145.77 0.0276
2026-02-13 2025-12-31 13F NOVARTIS Common Stock 66987V109 10,206 -7,708 -43.03 1,407 -38.75 0.0167
2025-11-14 2025-09-30 13F NOVARTIS Common Stock 66987V109 17,914 885 5.20 2,297 11.50 0.0205
2025-08-14 2025-06-30 13F NOVARTIS Common Stock 66987V109 17,029 -4,126 -19.50 2,061 -12.64 0.0207
2025-05-15 2025-03-31 13F NOVARTIS Common Stock 66987V109 21,155 -2,940 -12.20 2,358 0.60 0.0275
2025-02-14 2024-12-31 13F NOVARTIS Common Stock 66987V109 24,095 264 1.11 2,345 -14.48 0.0272
2024-11-14 2024-09-30 13F NOVARTIS Common Stock 66987V109 23,831 -536 -2.20 2,741 5.67 0.0334
2024-08-14 2024-06-30 13F NOVARTIS Common Stock 66987V109 24,367 450 1.88 2,594 12.15 0.0354
2024-05-15 2024-03-31 13F NOVARTIS Common Stock 66987V109 23,917 -879 -3.54 2,313 -7.59 0.0335
2024-02-13 2023-12-31 13F NOVARTIS Common Stock 66987V109 24,796 -2,103 -7.82 2,504 -8.62 0.0410
2023-11-15 2023-09-30 13F NOVARTIS Common Stock 66987V109 26,899 -327 -1.20 2,740 -0.29 0.0483
2023-08-15 2023-06-30 13F NOVARTIS Common Stock 66987V109 27,226 900 3.42 2,747 137,250.00 0.0471
2023-05-03 2023-03-31 13F NOVARTIS Common Stock 66987V109 26,326 -2,031 -7.16 2 0.00 0.0499
2023-02-13 2022-12-31 13F NOVARTIS Common Stock 66987V109 28,357 1,094 4.01 3 -99.90 0.0699
2022-11-14 2022-09-30 13F NOVARTIS Common Stock 66987V109 27,263 130 0.48 2,072 -9.68 0.0662
2022-08-08 2022-06-30 13F NOVARTIS Common Stock 66987V109 27,133 905 3.45 2,294 -0.30 0.0714
2022-05-12 2022-03-31 13F NOVARTIS Common Stock 66987V109 26,228 1,378 5.55 2,301 5.84 0.0703
2022-02-15 2021-12-31 13F NOVARTIS Common Stock 66987V109 24,850 4,337 21.14 2,174 29.56 0.0646
2021-11-15 2021-09-30 13F NOVARTIS Common Stock 66987V109 20,513 2,049 11.10 1,678 -0.42 0.0546
2021-08-13 2021-06-30 13F NOVARTIS Common Stock 66987V109 18,464 205 1.12 1,685 7.94 0.0597
2021-05-13 2021-03-31 13F NOVARTIS Common Stock 66987V109 18,259 2,475 15.68 1,561 4.77 0.0641
2021-02-12 2020-12-31 13F NOVARTIS Common Stock 66987V109 15,784 2,409 18.01 1,490 28.12 0.0705
2020-11-13 2020-09-30 13F NOVARTIS Common Stock 66987V109 13,375 294 2.25 1,163 1.75 0.0717
2020-07-30 2020-06-30 13F NOVARTIS Common Stock 66987V109 13,081 1,341 11.42 1,143 18.08 0.0822
2020-05-18 2020-03-31 13F NOVARTIS Common Stock 66987V109 11,740 2,173 22.71 968 6.84 0.0894
2020-02-20 2019-12-31 13F NOVARTIS Common Stock 66987V109 9,567 3,115 48.28 906 61.50 0.0764
2019-11-15 2019-09-30 13F NOVARTIS Common Stock 66987V109 6,452 1,757 37.42 561 30.47 0.0631
2019-08-15 2019-06-30 13F NOVARTIS Common Stock 66987V109 4,695 2,228 90.31 430 81.43 0.0563
2019-05-15 2019-03-31 13F NOVARTIS Common Stock 66987V109 2,467 2,467 237 0.0401
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.